Mutant IDH1 promotes leukemogenesis in vivo and can be specifically targeted in human AML

A. Chaturvedi, M.M.A. Cruz, N. Jyotsana, A. Sharma, H.Y. Yun, K. Gorlich, M. Wichmann, A. Schwarzer, M. Preller, F. Thol, J. Meyer, R. Haemmerle, E.A. Struys, E.E. Jansen, U. Modlich, Z.X. Li, L.M. Sly, R Geffers, R. Lindner, D.J. MansteinU. Lehmann, J. Krauter, A. Ganser, M. Heuser

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)2877-2887
JournalBlood
Volume122
Issue number16
DOIs
Publication statusPublished - 2013

Cite this

Chaturvedi, A., Cruz, M. M. A., Jyotsana, N., Sharma, A., Yun, H. Y., Gorlich, K., ... Heuser, M. (2013). Mutant IDH1 promotes leukemogenesis in vivo and can be specifically targeted in human AML. Blood, 122(16), 2877-2887. https://doi.org/10.1182/blood-2013-03-491571